Insmed Inc (INSM)

[supacharja]

Windy...I understand your quest, but I think that would ultimately be money unwisely spent. I have a sizable position in INSM as well and have consulted with a few "patent" attorney friends on this matter. The bottom line is that there is more to this story than we are privy too. The only ones that "think" they fully understand this situation are the attorney's for the respective parties involved. And that is a misnomer because it appears that a jury (unless a deal is struck) will decide the issues at hand, which as you can imagine, can go either way.

Personally, my feeling is that regardless of the outcome, INSM will not be put "out of business." As such, the current valuation is ridiculously low and completely disregards the prospects of the entire pipeline as well as the IGFD indication (worldwide). I'm basing this notion off of public comps as well as private biotech M&A transactions.

Unfortunately (or fortunately for those that view the weakness as a buying op) this is not uncommon in the world of microcaps. Share prices tend to swing irrationally in both directions. Equilibrium will not be reached until there is more visibility. As a result, I would expect continued share price volatility in the intermediate term.